$LLY getting crushed lately while $HIMS eats GLP-1 share.
Lilly must partner with Hims fast — or $HIMS + $NVO will bury them in affordable access.
No deal = Lilly loses big volumes to telehealth.
Tick tock ⚰️💨
#GLP1#Biotech
Shorts reloading hard on $HIMS again, trying to take back control after the squeeze tease 😈
Retail still holding strong – squeeze round 2 loading? 💥
#HIMS#ShortSqueeze